Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001387131-20-004485

Options or other derivatives

  • Chief Financial Officer acquired 720,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SAENGER BRADLEY · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-05-04 Grant or award : show line 1 in the form Stock Option +360,000 360,000 D
2020-05-04 Grant or award : show line 2 in the form Stock Option +360,000 360,000 D
Loading xslF345X03/ownership.xml…